---
layout: default
title: "AI for Drug Discovery"
date: 2021-09-01
categories: Project
---

## Generative AI for Molecular Design

We develop **generative artificial intelligence models** for *target-specific de novo molecular design*, with the goal of accelerating drug discovery and molecular optimization.

Our work focuses on learning chemical representations and structureâ€“property relationships directly from large-scale molecular data, enabling the automated generation of candidate compounds with desired biological profiles.

---

## cMolGPT

**cMolGPT** is a *conditional generative pre-trained Transformer* designed for **target-aware molecular generation**.  
By conditioning on protein targets, cMolGPT can generate chemically valid, diverse, and biologically relevant molecules tailored to specific therapeutic contexts.

**Key capabilities include:**

- Target-specific de novo molecule generation  
- High chemical validity and structural diversity  
- Improved hit discovery efficiency compared with unconditional models  
- Applicability to multiple drug targets and chemical spaces  

ðŸ“„ **Paper**:  
> *cMolGPT: A Conditional Generative Pre-Trained Transformer for Target-Specific De Novo Molecular Generation*  
> **Molecules**, 2023  
> [Read the article (MDPI)](https://www.mdpi.com/1420-3049/28/11/4430)

ðŸ’» **Code**:  
[https://github.com/VV123/cMolGPT](https://github.com/VV123/cMolGPT)

---

## Model Overview & Applications

<center>
<figure>
  <img src="{{ site.url }}{{ site.baseurl }}/images/drugdiscovery.png" style="width: 320px; box-shadow: none; margin: 10px;">
  <img src="{{ site.url }}{{ site.baseurl }}/images/EGFR.png" style="width: 200px; box-shadow: none; margin: 10px;">
  <img src="{{ site.url }}{{ site.baseurl }}/images/HTR1A.png" style="width: 200px; box-shadow: none; margin: 10px;">
  <img src="{{ site.url }}{{ site.baseurl }}/images/S1PR1.png" style="width: 200px; box-shadow: none; margin: 10px;">
</figure>
</center>

The framework has been evaluated on multiple therapeutic targets (e.g., **EGFR**, **HTR1A**, **S1PR1**), demonstrating its ability to generate target-enriched molecular libraries that support downstream screening and lead optimization.

---

## Industry Collaboration

<div style="display: flex; align-items: center; margin-top: 20px;">
  <img src="{{ site.url }}{{ site.baseurl }}/images/biogen.jpeg" width="120px" style="margin-right: 30px;">
  <p style="font-size: 0.95em;">
    This project is conducted in collaboration with <b>Biogen Inc.</b>, exploring the application of large language models and generative AI to real-world drug discovery pipelines.
  </p>
</div>

---

<style>
h2 {
  font-size: 1.4em;
  margin-top: 1.2em;
}
p, li {
  font-size: 0.95em;
  line-height: 1.5;
}
</style>
